Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Market Cap	2.33B
Revenue (ttm)	953.05M
Net Income (ttm)	69.63M
Shares Out	n/a
EPS (ttm)	0.94
PE Ratio	33.48
Forward PE	n/a
Dividend	0.62 (2.02%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	19
Open	30.60
Previous Close	30.60
Day's Range	30.60 - 30.60
52-Week Range	28.80 - 39.20
Beta	n/a
RSI	56.82
Earnings Date	Aug 5, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, coolin...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 3,615
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KOY

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial numbers in JPY